Related Experiment Video
Updated: Jun 26, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
256
Construction and validation of a nomogram for predicting disease-free survival after radical resection of rectal
Jiayi Sun1, Xinzhi Zhong1, Xiangqi Yin1
1Department of General Practice, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Journal of Gastrointestinal Oncology
|May 17, 2024
Summary
This study identifies key inflammatory markers that predict disease-free survival in rectal cancer patients post-surgery. A nomogram using these markers aids in identifying high-risk individuals for targeted treatment.
Area of Science:
- Oncology
- Surgical Oncology
- Inflammatory Markers
Background:
- Colorectal cancer poses a significant threat to patient survival and quality of life.
- Surgery is the primary treatment, but outcomes vary widely.
- Predicting postoperative prognosis in rectal cancer remains challenging.
Purpose of the Study:
- To investigate the influence of perioperative inflammatory indicators on disease-free survival (DFS) after rectal cancer resection.
- To develop a predictive nomogram for clinical use in assessing DFS risk.
Main Methods:
- Retrospective analysis of 304 rectal adenocarcinoma patients undergoing laparoscopic radical resection.
- Utilized a training (n=213) and validation (n=91) set.
- Employed LASSO-Cox regression to identify independent risk factors and construct a nomogram, validated using ROC, calibration curves, and DCA.
Main Results:
- TNM stage III, neural invasion, preoperative neutrophil-to-lymphocyte ratio (NLR) ≥1.995, postoperative systemic immune-inflammation index (SII) ≥451.05, and Δpan-immune-inflammation value (ΔPIV) ≥144.36 were significant predictors of 3-year DFS.
- The nomogram demonstrated good predictive accuracy with AUCs of 0.811 (training) and 0.808 (validation).
- The nomogram exhibited strong calibration and clinical utility.
Conclusions:
- A nomogram incorporating TNM stage, neural invasion, preoperative NLR, postoperative SII, and ΔPIV effectively predicts 3-year DFS in rectal cancer patients.
- This tool facilitates identification of high-risk patients for intensified postoperative monitoring and adjuvant therapy.
- The nomogram offers valuable clinical reference for personalized rectal cancer management.

